tiprankstipranks
Entheon Biomedical (ENTBF)
OTHER OTC:ENTBF
US Market

Entheon Biomedical (ENTBF) Income Statement

Compare
34 Followers

Entheon Biomedical Income Statement

Last quarter (Q3 2024), Entheon Biomedical's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Entheon Biomedical's net income was C$-64.70K. See Entheon Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Mar 19
Total Revenue
C$ 250.32KC$ 189.68KC$ 21.67KC$ 0.00C$ 0.00
Gross Profit
C$ 250.32KC$ 187.58KC$ 9.13KC$ -2.72KC$ 0.00
Operating Expenses
C$ 564.32KC$ 3.79MC$ 9.12MC$ 4.38MC$ 170.02K
Depreciation and Amortization
C$ 313.99KC$ 2.10KC$ 3.84KC$ 2.72KC$ -31.01K
EBITDA
C$ 13.99KC$ -3.60MC$ -8.18MC$ -1.64MC$ -229.38K
Operating Income
C$ -313.99KC$ -3.55MC$ -9.31MC$ -4.37MC$ -170.02K
Other Income/Expenses
C$ 13.99KC$ 1.54MC$ 215.87KC$ -8.82KC$ -60.07K
Pretax Income
C$ -300.00KC$ -2.06MC$ -8.89MC$ -4.38MC$ -230.09K
Net Income
C$ -300.00KC$ -7.03MC$ -8.67MC$ -4.38MC$ -157.53K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.05C$ -0.12C$ -0.15C$ -1.60C$ -0.04
Diluted EPS
C$ -0.05C$ -0.12C$ -0.15C$ -1.60C$ -0.04
Weighted Average Shares Outstanding
5.91M 59.09M 56.83M 2.74M 4.18M
Weighted Average Shares Outstanding (Diluted)
5.91M 59.09M 56.87M 2.74M 4.18M
Currency in CAD

Entheon Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis